Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628964 · ClinicalTrials.gov registry record · NA
Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
A NA study of Smoking and Tobacco Use Disorder, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02628964: Completed NA study of Smoking and Tobacco Use Disorder, sponsored by NYU Langone Health.
NCT02628964 is a NA study of Smoking and Tobacco Use Disorder that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02628964, a NA study of Smoking and Tobacco Use Disorder, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility of using e-cigarettes as a method for harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking outcomes. Participants will be randomized to receive either e-cigarettes with nicotine cartridges or e-cigarettes with placebo cartridges, and followed for 3 weeks.
Conditions Studied
Interventions
- DEVICE e-cigarettes
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-03-26 |
| Phase | NA |
What the finished NCT02628964 record still lists
NCT02628964 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which e-cigarettes is the first listed.
NCT02628964 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02628964 about?
NCT02628964 is a clinical study titled "Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy". The purpose of this study is to examine the feasibility of using e-cigarettes as a method for harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking outcomes. Participants will be randomized to receive either e-cigarettes with nicotine cartridges or e-cigarette...
What is the current status of trial NCT02628964?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-05. Estimated completion is 2018-03-26.
What conditions does trial NCT02628964 study?
This clinical trial studies the following conditions: Smoking, Tobacco Use Disorder.
What interventions are being tested in trial NCT02628964?
The interventions under investigation include: e-cigarettes (DEVICE).
Who is sponsoring clinical trial NCT02628964?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02628964 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02628964's enrollment target sits among peer trials
100 73rd of 123 higher than 48 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia